Vatalanib free base
98%
- Product Code: 124927
CAS:
212141-54-3
| Molecular Weight: | 346.8129 g./mol | Molecular Formula: | C₂₀H₁₅ClN₄ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD08458963 | |
| Melting Point: | Boiling Point: | 587.8℃ at 760 mmHg | |
| Density: | 1.33g/ml | Storage Condition: | -20℃ |
Product Description:
Vatalanib free base is primarily used in research and clinical settings as a potent inhibitor of vascular endothelial growth factor receptors (VEGFRs). It is studied for its potential to inhibit angiogenesis, the process by which new blood vessels form, which is crucial in the growth and spread of tumors. By targeting VEGFRs, it aims to cut off the blood supply to cancerous tissues, thereby slowing tumor progression. This compound has been explored in clinical trials for treating various cancers, including colorectal cancer and glioblastoma. Its application extends to understanding molecular pathways involved in angiogenesis and developing targeted cancer therapies.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White To Off-White To Beige Powder Or Crystals |
| Purity (%) | 97.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | ฿860.00 |
+
-
|
| 0.005 | 10-20 days | ฿3,390.00 |
+
-
|
Vatalanib free base
Vatalanib free base is primarily used in research and clinical settings as a potent inhibitor of vascular endothelial growth factor receptors (VEGFRs). It is studied for its potential to inhibit angiogenesis, the process by which new blood vessels form, which is crucial in the growth and spread of tumors. By targeting VEGFRs, it aims to cut off the blood supply to cancerous tissues, thereby slowing tumor progression. This compound has been explored in clinical trials for treating various cancers, including colorectal cancer and glioblastoma. Its application extends to understanding molecular pathways involved in angiogenesis and developing targeted cancer therapies.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :